Singleplex and Multiplex Bead Based Immunoassays
Abcam 8-Hydro x yguanosine, biomarker for o x idative damage, 1MG
MW 299.24 Da, Purity >98%. Biomarker for oxidative damage to nucleic acids and lipids. Product of oxidative damage of RNA. Promotes differentiation and shows antiproliferative effects.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (+)-JQ1, BET bromodomain inhibitor, 1MG
MW 457 Da, Purity >99%. Potent, selective and cell-permeable BET bromodomain inhibitor (Kd values are 50 and 90 nM at BRD4 first and second bromodomains, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam (+)-JQ1 (DMSO solution), BET bromodomain inhibitor, 1MG-LQD
MW 457 Da, Purity >99%. Potent, selective and cell-permeable BET bromodomain inhibitor (Kd values are 50 and 90 nM at BRD4 first and second bromodomains, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bindarit, CCL2, CCL7 and CCL8 inhibitor, 50MG
MW 324.4 Da, Purity >99%. CCL2, CCL7 and CCL8 inhibitor. Anti-inflammatory agent. Shows antiproliferative, antimetastatic and antitumor effects in vivo. Prevents neuroinflammation in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bindarit, CCL2, CCL7 and CCL8 inhibitor, 5MG
MW 324.4 Da, Purity >99%. CCL2, CCL7 and CCL8 inhibitor. Anti-inflammatory agent. Shows antiproliferative, antimetastatic and antitumor effects in vivo. Prevents neuroinflammation in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Folic acid (Folate), Synthetic vitamin B9, 25G
MW 441.4 Da, Purity >96%. Synthetic vitamin B9. Tetrahydrofolate precursor. Promotes DNA synthesis and cell division. Shows anti-inflammatory and chemopreventive effects *in vivo.* Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam MK 212 hydrochloride, 5-HT2C receptor agonist, 50MG
MW 235.11 Da, Purity >99%. Potent, selective 5-HT2C receptor agonist (IC50 values are 28 and 420 nM for 5-HT2C and 5-HT2A receptors, respectively). Shows anxiogenic effects and decreases locomotor activity *in vivo.*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (+)-JQ1, BET bromodomain inhibitor, 5MG
MW 457 Da, Purity >99%. Potent, selective and cell-permeable BET bromodomain inhibitor (Kd values are 50 and 90 nM at BRD4 first and second bromodomains, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bindarit, CCL2, CCL7 and CCL8 inhibitor, 25MG
MW 324.4 Da, Purity >99%. CCL2, CCL7 and CCL8 inhibitor. Anti-inflammatory agent. Shows antiproliferative, antimetastatic and antitumor effects in vivo. Prevents neuroinflammation in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam MK 212 hydrochloride, 5-HT2C receptor agonist, 10MG
MW 235.11 Da, Purity >99%. Potent, selective 5-HT2C receptor agonist (IC50 values are 28 and 420 nM for 5-HT2C and 5-HT2A receptors, respectively). Shows anxiogenic effects and decreases locomotor activity *in vivo.*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Pyrido x al- 5'-phosphate monohydrate, Vitamin B6 metabolite, 25G
MW 265.16 g/mol, Purity >98%. Vitamin B6 metabolite that acts as a coenzyme in transamination reactions by forming a Schiff-base linkage with lysine groups on aminotransferase. Also serves as a coenzyme in some decarboxylation and deamination reactions. Can modify lysyl and valyl residues in proteins. Has the ability to inhibit purinergic receptors and intracellular influx of Ca²+.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Pyrido x al- 5'-phosphate monohydrate, Vitamin B6 metabolite, 5G
MW 265.16 g/mol, Purity >98%. Vitamin B6 metabolite that acts as a coenzyme in transamination reactions by forming a Schiff-base linkage with lysine groups on aminotransferase. Also serves as a coenzyme in some decarboxylation and deamination reactions. Can modify lysyl and valyl residues in proteins. Has the ability to inhibit purinergic receptors and intracellular influx of Ca²+.
The product is subject to the following: Abcam Restricted Use Statement